Health Care

Healthcare Stocks Highlights: Astrazeneca PLC (NYSE:AZN) , Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

0 3

Astrazeneca PLC (NYSE:AZN) initiated the shares trading at $33.15 and showed negative change of -0.27% while the stock’s final trade was registered at $ 33.21. However, its previous closing price was seen at $33.30. The stock negotiated total number of 4.69 million shares as compared to 3 months average volume of 6.08 million shares.

The stock price demonstrated downbeat change from its 50 day moving average of 32.72 and had been up from its 200 Day Moving Average of 30.03.

Brokerage Recommendations:

The stock has received ratings from many brokerage firms according to ZACKS. Currently shares have been rated as “Buy” from “0” brokerage firms and “1” brokerage firms say as “Strong Buy”. “0” brokerage firms have suggested “Sell” for the company. “3” brokerage firms have recommended as a “Hold”. Strong Sell rating was given by “0” brokerage firms.  The Company has average brokerage recommendation (ABR) of “2.5” based on consensus of the ZACKS brokerage firms.

The average true range of AstraZeneca PLC’s (AZN) is recorded at 0.53 and the relative strength index of the stock stands 54.47. The stock price is going above to its 52 week low with 24.78% and lagging behind from its 52 week high with -3.96%. Analyst recommendation for this stock stands at 2.60. A look on the firm performance, its monthly performance is -0.55% and a quarterly performance of 14.27%. The stock price is trading upbeat from its 200 days moving average with 10.34% and up from 50 days moving average with 5.70%.

Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) declined -0.55% and ended at $129.87 smaller than previous closing price of $130.59. The total 1.09 million shares were bought and sold throughout the most recent trading session less than average volume of 1.62 million shares.

Brokerage Recommendations:

The stock has received ratings from many brokerage firms according to ZACKS. Currently shares have been rated as “Buy” from “3” brokerage firms and “12” brokerage firms say as “Strong Buy”. “0” brokerage firms have suggested “Sell” for the company. “7” brokerage firms have recommended as a “Hold”. Strong Sell rating was given by “0” brokerage firms.  The Company has average brokerage recommendation (ABR) of “1.75” based on consensus of the ZACKS brokerage firms.

Zimmer Biomet Holdings, Inc.’s (ZBH) has price-to-cash ratio of 26.33 and price to sale ratio of 3.41. The company net profit margin is 4.40% and gross profit margin is 68.00%. A look on the firm performance, its monthly performance is -0.91% and a quarterly performance of 6.54%. The stock price is moving up from its 20 days moving average with 0.22% and isolated positively from 50 days moving average with 3.43%.

About the author / 

Leave a reply

Your email address will not be published. Required fields are marked *

Advirtisement

About Us

WSnews4investors is the influential source for financial news and Opinion Company with content which delivered over the Internet. WSnews4investors is a dynamic and innovative financial media outlet that empowers investors with high-quality, unique content that is coveted by Wall Street’s traders.

Newsletter